Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matteo Malagrinò"'
Autor:
Matteo Malagrinò, Guido Zavatta
Publikováno v:
Women's Health, Vol 19 (2023)
In estrogen-receptor-positive tumors, adjuvant endocrine therapy has been shown to be highly beneficial for both overall and disease-free survival. Estradiol is key in regulating bone and mineral physiology, and several studies found a strong correla
Externí odkaz:
https://doaj.org/article/09ded26b65a24e1786a5ebc87c964ff2
Autor:
Guido Zavatta, Valentina Vicennati, Paola Altieri, Lorenzo Tucci, Giacomo Colombin, Kimberly Coscia, Cristina Mosconi, Caterina Balacchi, Flaminia Fanelli, Matteo Malagrinò, Matteo Magagnoli, Rita Golfieri, Uberto Pagotto, Guido Di Dalmazi
Publikováno v:
European Journal of Endocrinology. 188:343-352
Objective Mild autonomous cortisol secretion (MACS) has been associated with a higher prevalence of osteoporosis, although most data rely on single-center studies with limited sample size. We aimed to assess the prevalence of fragility fractures and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d8f9a97a1dcbc9f81729fb51191d83f
https://doi.org/10.1093/ejendo/lvad038
https://doi.org/10.1093/ejendo/lvad038
Autor:
Guido Zavatta, Matteo Malagrinò
Publikováno v:
Women's Health. 19:174550572211494
In estrogen-receptor-positive tumors, adjuvant endocrine therapy has been shown to be highly beneficial for both overall and disease-free survival. Estradiol is key in regulating bone and mineral physiology, and several studies found a strong correla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85cdeddb8d36c43721e37f3dd8667e09
https://doi.org/10.1177/17455057221149493
https://doi.org/10.1177/17455057221149493
Autor:
Renato Pascale, Giuseppe Ferraro, Linda Bussini, Matteo Malagrinò, Lorenzo Marconi, Livia Pancaldi, Alice Toschi, Pierluigi Viale, Michele Bartoletti, Maddalena Giannella, Simone Ambretti, Russell E. Lewis
Publikováno v:
Open Forum Infectious Diseases
Background To compare the prognostic utility of the new definition of difficult-to-treat resistance (DTR) vs established definitions in a cohort of patients with Gram-negative bloodstream infections (GNBSIs). Methods This was a retrospective single-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9a2ddbdee08c15b777feaca7af4f85
https://pubmed.ncbi.nlm.nih.gov/31858018
https://pubmed.ncbi.nlm.nih.gov/31858018